Trials / Completed
CompletedNCT02646488
Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 276 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Million Hearts ABCS 6 Months | The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). |
| BEHAVIORAL | Million Hearts ABCS 9 Months | The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). |
| BEHAVIORAL | Million Hearts ABCS 12 Months | The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). |
| BEHAVIORAL | Million Hearts ABCS 15 Months | The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). |
| BEHAVIORAL | Standard Care Regimen 9 Months | |
| BEHAVIORAL | Standard Care Regimen 12 Months | |
| BEHAVIORAL | Standard Care Regimen 15 Months | |
| BEHAVIORAL | Standard Care Regimen 18 Months | |
| BEHAVIORAL | Standard Care Regimen 21 Months | |
| BEHAVIORAL | Standard Care Regimen 24 Months | |
| BEHAVIORAL | Standard Care Regimen 27 Months | |
| BEHAVIORAL | Follow Up Post Intervention 21 Months | |
| BEHAVIORAL | Follow Up Post Intervention 24 Months | |
| BEHAVIORAL | Follow Up Post Intervention 27 Months | |
| BEHAVIORAL | Follow Up Post Intervention 30 Months | |
| BEHAVIORAL | Follow Up Post Intervention 33 Months |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2016-01-05
- Last updated
- 2019-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02646488. Inclusion in this directory is not an endorsement.